Access to innovative pharmaceutical drugs: Is the demographic challenge considered in the development plan?
- At: 2016 FIP Congress in Buenos Aires (Argentina)
- Type: Poster
- By: HOLBEIN, Baerbel (University of Bremen, Lilienthal, Germany)
- Co-author(s): Baerbel Holbein:
Healthcare systems need to ensure medication for all patient populations are available, particularly for the fastest growing group of elderly patients. The development of innovative drugs, particularly for the treatment of the 65+-population, is risky, costly and higly complex. Within innovation economics, the theory of parallel paths is applied,.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.